The total return over the past 12 months is +83.46% vs. +16.94% for the S&P 500. So far it's up +81.06% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +83.46% | +128.23% | (1.42%) | N/A | N/A | N/A |
| Total Return CAGR | +83.46% | +128.23% | (1.42%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Candel Therapeutics, Inc. (CADL)
| Year | Start price | End price | CADL Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.65 | $10.23 | +81.06% | +14.51% | +66.55% |
| 2025 | $8.68 | $5.65 | (34.91%) | +17.72% | (52.63%) |
| 2024 | $1.47 | $8.68 | +490.48% | +24.89% | +465.59% |
| 2023 | $1.79 | $1.47 | (17.88%) | +26.19% | (44.07%) |
| 2022 | $7.82 | $1.79 | (77.11%) | (18.17%) | (58.94%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
